New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
07:02 EDTMGNXCMC Biologics and MacroGenics enter masters services agreement
CMC Biologics and MacroGenics have entered into a Master Services Agreement for process validation activities and clinical manufacturing of another of MacroGenics' oncology product candidates.
News For MGNX From The Last 14 Days
Check below for free stories on MGNX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
17:20 EDTMGNXMacroGenics IND MGD007 cleared by FDA to start enrolling patients
MacroGenics announced that its investigational new drug, or IND, for MGD007 has been cleared by the FDA to proceed with the phase 1 human clinical trial for this drug candidate. MGD007 is a Dual-Affinity Re-Targeting protein being developed for the treatment of colorectal cancer. MacroGenics will receive a $5M milestone payment from Servier, France's largest privately-held pharmaceutical company, triggered by the IND clearance.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use